371 related articles for article (PubMed ID: 19497773)
1. Catheter-related fungemia caused by Candida intermedia.
Ruan SY; Chien JY; Hou YC; Hsueh PR
Int J Infect Dis; 2010 Feb; 14(2):e147-9. PubMed ID: 19497773
[TBL] [Abstract][Full Text] [Related]
2. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
Angel-Moreno A; Boronat M; Bolaños M; Carrillo A; González S; Pérez Arellano JL
J Infect; 2005 Oct; 51(3):e85-7. PubMed ID: 16230210
[TBL] [Abstract][Full Text] [Related]
3. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
4. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
[TBL] [Abstract][Full Text] [Related]
6. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy.
Buckler BS; Sams RN; Goei VL; Krishnan KR; Bemis MJ; Parker DP; Murray DL
Pediatr Infect Dis J; 2008 Aug; 27(8):762-4. PubMed ID: 18664989
[TBL] [Abstract][Full Text] [Related]
7. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.
Fujita S; Senda Y; Okusi T; Ota Y; Takada H; Yamada K; Kawano M
J Clin Microbiol; 2007 Oct; 45(10):3459-61. PubMed ID: 17652473
[TBL] [Abstract][Full Text] [Related]
8. Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature.
Minces LR; Ho KS; Veldkamp PJ; Clancy CJ
Scand J Infect Dis; 2009; 41(11-12):892-7. PubMed ID: 19922077
[TBL] [Abstract][Full Text] [Related]
9. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
10. Catheter-related fungemia due to Candida thermophila.
Bar-Meir M; Sutton DA; Wickes B; Kurtzman CP; Goldman S; Zheng X
J Clin Microbiol; 2006 Aug; 44(8):3035-6. PubMed ID: 16891536
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Colombo AL
Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
[TBL] [Abstract][Full Text] [Related]
12. Electrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or pecurrent fungemia.
Shin JH; Shin DH; Song JW; Kee SJ; Suh SP; Ryang DW
J Clin Microbiol; 2001 Apr; 39(4):1258-63. PubMed ID: 11283038
[TBL] [Abstract][Full Text] [Related]
13. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
14. A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.
Vervaeke S; Vandamme K; Boone E; De Laere E; Swinne D; Surmont I
Med Mycol; 2008 Dec; 46(8):853-6. PubMed ID: 18798049
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
[TBL] [Abstract][Full Text] [Related]
16. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].
Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
Clancy CJ; Staley B; Nguyen MH
Antimicrob Agents Chemother; 2006 Oct; 50(10):3496-8. PubMed ID: 17005842
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
19. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
